Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Cognition and Behavior

The Role of GABA in the Dorsal Striatum-Raphe Nucleus Circuit Regulating Stress Vulnerability in Male Mice with High Levels of Shati/Nat8l

Hajime Miyanishi, Shiori Suga, Kazuyuki Sumi, Miho Takakuwa, Naotaka Izuo, Takashi Asano, Shin-ichi Muramatsu and Atsumi Nitta
eNeuro 9 October 2023, 10 (10) ENEURO.0162-23.2023; https://doi.org/10.1523/ENEURO.0162-23.2023
Hajime Miyanishi
1Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiori Suga
1Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuyuki Sumi
1Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miho Takakuwa
1Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naotaka Izuo
1Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Asano
1Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shin-ichi Muramatsu
2Division of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University, Shimotsuke 329-0498, Japan
3Center for Gene & Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo 108-0071, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsumi Nitta
1Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Atsumi Nitta
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Decreased 5-HT content in the dSTR is correlated with depression-like behaviors. a–c, Results of social interaction test. a, Time in the interaction zone. Naive, n = 9; Resilient, n = 8; Susceptible, n = 8; ***p < 0.005 versus susceptible mice (one-way ANOVA with Bonferroni’s post hoc tests). b, Interaction ratio. Naive, n = 9; Resilient, n = 8; Susceptible, n = 8; ***p < 0.005 versus susceptible mice (one-way ANOVA with Bonferroni’s post hoc tests). c, Time in avoidance zone. Naive, n = 9; Resilient, n = 8; Susceptible, n = 8; ***p < 0.005 versus susceptible mice, **p < 0.01 versus susceptible mice (one-way ANOVA with Bonferroni’s post hoc tests). d, Quantitative of basal 5-HT levels in the dSTR. Naive, n = 7; Resilient, n = 7; Susceptible, n = 6; **p < 0.01 versus susceptible mice, *p < 0.05 versus susceptible mice (one-way ANOVA with Bonferroni’s post hoc tests). e, f, Correlation of basal 5-HT content in the dSTR with the social interaction ability assessed by the time spent in interaction zone (e) and by interaction ratio (f) after RSDS. Resilient, n = 7; Susceptible, n = 6 (Pearson’s correlation test).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Pharmacogenetic activation of serotonergic neurons in the dRN. a, Schematic of microinjection of AAV vectors into the dRN and microinfusion of DCZ into the dSTR. b, Representative images of injection sites (dRN). TPH-positive cells: red signal; EYFP-positive cells: green signal. Entire portion (left), Scale bars: 200 μm. Magnified portion (right), Scale bars: 20 μm. c, 5-HT content in dSTR collected every 12 min for 2 h from the time DCZ was microinfused. dRN-Mock with Ringer, n = 4; dRN-Mock with DCZ, n = 5; dRN-hM3Dq with Ringer, n = 5; dRN- hM3Dq with DCZ, n = 5; ***p < 0.005 versus dRN-Mock with Ringer, **p < 0.05 versus dRN-Mock with Ringer (two-way ANOVA with Bonferroni’s post hoc tests).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Upregulation of 5-HT content in the dSTR induced resilience to stress in dSTR-Shati OE mice. a, Representative images of injection sites (dSTR). Shati/Nat8l (His-positive cells): green signal, NeuN-positive cells: red signal. Entire portion (right), Scale bars: 500 μm. Magnified portion (left), Scale bars: 50 μm. b, Relative expression level of Shati/Nat8l mRNA in the dSTR. dSTR-Mock, n = 8; dSTR-Shati OE, n = 7; **p < 0.01 versus dSTR-Mock mice (student t test). c, Schematic of microinjection and microinfusion and the timeline of experiments. d–f, Results of social interaction test. d, Time in the interaction zone. dSTR-Mock with ringer, n = 10; dSTR-Mock with DCZ, n = 11; dSTR-Shati OE with Ringer, n = 11; dSTR-Shati OE with DCZ, n = 11; ***p < 0.005 versus dSTR-Mock with Ringer; ###p < 0.005 versus dSTR-Shati OE with DCZ (two-way ANOVA with Bonferroni’s post hoc tests). e, Interaction ratio. dSTR-Mock with Ringer, n = 10; dSTR-Mock with DCZ, n = 11; dSTR-Shati OE with Ringer, n = 11; dSTR-Shati OE with DCZ, n = 11; ***p < 0.005 versus dSTR-Mock with Ringer; ##p < 0.01 versus dSTR-Shati OE with DCZ (two-way ANOVA with Bonferroni’s post hoc tests). f, Time in avoidance zone. dSTR-Mock with Ringer, n = 10; dSTR-Mock with DCZ, n = 11; dSTR-Shati OE with Ringer, n = 11; dSTR-Shati OE with DCZ, n = 11; **p < 0.01 versus dSTR-Mock with Ringer; ###p < 0.005 versus dSTR-Shati OE with DCZ (two-way ANOVA with Bonferroni’s post hoc tests). g, Result of sucrose preference test. dSTR-Mock with Ringer, n = 10; dSTR-Mock with DCZ, n = 11; dSTR-Shati OE with Ringer, n = 11; dSTR-Shati OE with DCZ, n = 11; ***p < 0.005 versus dSTR-Mock with ringer; ##p < 0.01 versus dSTR-Shati OE with DCZ (two-way ANOVA with Bonferroni’s post hoc tests). h, Immobility time in tail suspension test. dSTR-Mock with Ringer, n = 10; dSTR-Mock with DCZ, n = 11; dSTR-Shati OE with Ringer, n = 11; dSTR-Shati OE with DCZ, n = 11; *p < 0.05 versus dSTR-Mock with Ringer (two-way ANOVA with Tukey’s post hoc tests). i, Immobility time in a forced swimming test. dSTR-Mock with Ringer, n = 10; dSTR-Mock with DCZ, n = 11; dSTR-Shati OE with Ringer, n = 11; dSTR-Shati OE with DCZ, n = 11; *p < 0.05 versus dSTR-Mock with Ringer; #p < 0.05 versus dSTR-Shati OE with DCZ (two-way ANOVA with Bonferroni’s post hoc tests). j, Results of locomotor activity test. dSTR-Mock with Ringer, n = 10; dSTR-Mock with DCZ, n = 11; dSTR-Shati OE with Ringer, n = 11; dSTR-Shati OE with DCZ, n = 11 (two-way ANOVA with Bonferroni’s post hoc tests).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    GABA content in the dRN is correlated with depression-like behaviors and controlled by Shati/Nat8l in the dSTR. a, Quantitative basal GABA content in the dRN. Naive, n = 9; Resilient, n = 8; Susceptible, n = 8; **p < 0.01 versus susceptible mice; *p < 0.05 versus susceptible mice (one-way ANOVA with Bonferroni’s post hoc tests). b, c, Correlation of basal GABA content in the dRN with the social interaction ability assessed by the time spent in interaction zone (b) and by interaction ratio (c) after RSDS. Resilient, n = 8; Susceptible, n = 8 (Pearson’s correlation test). d, Quantitative basal GABA content in the dRN. Mock, n = 8; dSTR-Shati, n = 7; **p < 0.01 versus Mock mice (student t test).

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Blockade of GABA signaling in the dRN suppressed stress vulnerability in dSTR-Shati OE mice. a, Schematic of microinjection and microinfusion and the timeline of experiments. b–d, Results of social interaction test. b, Time in the interaction zone. dSTR-Mock with ringer, n = 10; dSTR-Mock with CGP36216, n = 11; dSTR-Shati OE with Ringer, n = 9; dSTR-Shati OE with CGP36216, n = 9; ***p < 0.005 versus dSTR-Mock with Ringer; ###p < 0.005 versus dSTR-Shati OE with CGP362160 (two-way ANOVA with Bonferroni’s post hoc tests). c, Interaction ratio. dSTR-Mock with Ringer, n = 10; dSTR-Mock with CGP36216, n = 10; dSTR-Shati OE with Ringer, n = 9; dSTR-Shati OE with CGP36216, n = 9; ***p < 0.005 versus dSTR-Mock with Ringer; ##p < 0.01 versus dSTR-Shati OE with CGP36216 (two-way ANOVA with Bonferroni’s post hoc tests). d, Time in avoidance zone. dSTR-Mock with Ringer, n = 10; dSTR-Mock with CGP36216, n = 10; dSTR-Shati OE with Ringer, n = 9; dSTR-Shati OE with CGP36216, n = 9; **p < 0.01 versus dSTR-Mock with Ringer; ##p < 0.01 versus dSTR-Shati OE with CGP36216 (two-way ANOVA with Bonferroni’s post hoc tests). e, Result of sucrose preference test. dSTR-Mock with Ringer, n = 10; dSTR-Mock with CGP36216, n = 10; dSTR-Shati OE with Ringer, n = 9; dSTR-Shati OE with CGP36216, n = 9; ***p < 0.005 versus dSTR-Mock with ringer; ##p < 0.01 versus dSTR-Shati OE with CGP36216 (two-way ANOVA with Bonferroni’s post hoc tests). f, Immobility time in tail suspension test. dSTR-Mock with Ringer, n = 10; dSTR-Mock with CGP36216, n = 10; dSTR-Shati OE with Ringer, n = 9; dSTR-Shati OE with CGP36216, n = 9; **p < 0.01 versus dSTR-Mock with Ringer; ###p < 0.005 versus dSTR-Shati OE with CGP36216 (two-way ANOVA with Tukey’s post hoc tests). g, Immobility time in a forced swimming test. dSTR-Mock with Ringer, n = 10; dSTR-Mock with CGP36216, n = 10; dSTR-Shati OE with Ringer, n = 9; dSTR-Shati OE with CGP36216, n = 9; **p < 0.01 versus dSTR-Mock with Ringer; ###p < 0.005 versus dSTR-Shati OE with CGP36216 (two-way ANOVA with Tukey’s post hoc tests). h, Results of locomotor activity test. dSTR-Mock with Ringer, n = 10; dSTR-Mock with CGP36216, n = 10; dSTR-Shati OE with Ringer, n = 9; dSTR-Shati OE with CGP36216, n = 9 (two-way ANOVA with Bonferroni’s post hoc tests).

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Overexpression of Shat/Nat8l enhanced BDNF expression in the dSTR. Relative expression level of Shati/Nat8l mRNA in the dSTR. dSTR-Mock, n = 6; dSTR-Shati OE, n = 5; *p < 0.05 versus dSTR-Mock mice (student t test).

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Hypothesized mechanism of establishment of stress vulnerability after RSDS. Overview of dSTR-dRN circuitry changes in the mouse brain after RSDS. Shati/Nat8l in the dSTR was increased by RSDS, and BDNF expression in the dSTR and GABA release in the dRN was increased. The serotonergic system in the dRN is deactivated by elevated GABA content, and the 5-HT content in the dSTR is decreased. Finally, stress vulnerability is established, leading to depression-like behaviors in response to stress.

Back to top

In this issue

eneuro: 10 (10)
eNeuro
Vol. 10, Issue 10
October 2023
  • Table of Contents
  • Index by author
  • Masthead (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Role of GABA in the Dorsal Striatum-Raphe Nucleus Circuit Regulating Stress Vulnerability in Male Mice with High Levels of Shati/Nat8l
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
The Role of GABA in the Dorsal Striatum-Raphe Nucleus Circuit Regulating Stress Vulnerability in Male Mice with High Levels of Shati/Nat8l
Hajime Miyanishi, Shiori Suga, Kazuyuki Sumi, Miho Takakuwa, Naotaka Izuo, Takashi Asano, Shin-ichi Muramatsu, Atsumi Nitta
eNeuro 9 October 2023, 10 (10) ENEURO.0162-23.2023; DOI: 10.1523/ENEURO.0162-23.2023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
The Role of GABA in the Dorsal Striatum-Raphe Nucleus Circuit Regulating Stress Vulnerability in Male Mice with High Levels of Shati/Nat8l
Hajime Miyanishi, Shiori Suga, Kazuyuki Sumi, Miho Takakuwa, Naotaka Izuo, Takashi Asano, Shin-ichi Muramatsu, Atsumi Nitta
eNeuro 9 October 2023, 10 (10) ENEURO.0162-23.2023; DOI: 10.1523/ENEURO.0162-23.2023
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Result
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
    • Author Response
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • 5-hydroxytryptamine
  • dorsal raphe nucleus
  • dorsal striatum
  • Shati/Nat8l
  • stress
  • stress sensitivity

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Fast spiking interneurons autonomously generate fast gamma oscillations in the medial entorhinal cortex with excitation strength tuning ING–PING transitions
  • The serotonin 1B receptor modulates striatal activity differentially based on behavioral context
  • Population-level age effects on the white matter structure subserving cognitive flexibility in the human brain
Show more Research Article: New Research

Cognition and Behavior

  • The serotonin 1B receptor modulates striatal activity differentially based on behavioral context
  • Population-level age effects on the white matter structure subserving cognitive flexibility in the human brain
  • Neck Vascular Biomechanical Dysfunction Precedes Brain Biochemical Alterations in a Murine Model of Alzheimer’s Disease
Show more Cognition and Behavior

Subjects

  • Cognition and Behavior
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2026 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.